Millipore's addition of the full-length mTOR to the KinaseProfiler panel provides high-quality, confidential screening of compounds against this critically important kinase
The mTOR kinase has recently been linked to many important human diseases, including cancer, diabetes, obesity, cardiovascular disease ad neurological disorders.
The kinase enables the regulation of cell cycle progression, cell growth, protein synthesis, ribosome biogenesis and autophagy, important target factors in the study of mTOR related diseases.
Millipore's bioscience division provides innovative tools, services and biological reagents that drive advancements in biomedical and academic research as well as support the discovery and development of new pharmaceuticals.
The product portfolio has been further enhanced with the 2006 addition of Chemicon, Upstate and Linco product lines, allowing Millipore to provide the most complete offering of life science tools on the market.
